Cybin Inc Revenue per Employee (CYBN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cybin Inc   (NYSEAMER: CYBN)
 

Cybin Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 123.74% in the fourth quarter 2025, year on year to cumulative value of $159 million, Cybin Inc 's revenue per employee grew on a trailing twelve months basis to $ 5,304,933, this marks a new company high.
Within the Healthcare sector Employees of 4 other companies have achieved higher revenue per employee. While Cybin Inc 's total ranking has deteriorated compared to the previous quarter from to 178. Cybin Inc has 30 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYBN Revenue per Employee (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Revenue Change 123.74 % - - - -
Sales per Employee (TTM) $ 5,304,933 2,371,000 2,371,000 2,371,000 2,371,000
CYBN's Total Ranking # 178 # # # # 376
Seq. Revenue Change - - - - -

CYBN Company Profile >> Back to CYBN Efficiency Comparisons >> Compare CYBN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 5
Overall Market # 178

Revenue per Employee Statistics
High Average Low
$ 5,304,933 $ 3,837,966 $ 2,371,000
(Mar 31 2025)   (Mar 31 2024)



Financial Statements
Cybin Inc 's Revenue MRQ $ 159 Millions Visit CYBN's Income Statement
Cybin Inc 's Revenues TTM $ 159 Millions Visit CYBN's aggregate revenue growth
What are CYBN's Sales? Visit CYBN's Sales by Segment




Other Ratios
Cybin Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CYBN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CYBN's Competitors
Revenue per Employee for CYBN's Suppliers
Revenue per Employee for CYBN's Customers

You may also want to know
CYBN's Sales Growth Rates CYBN's Pe Price to earnings ratio CYBN's Receivables Turnover Ratio CYBN's Stock Quote
CYBN's Net Income Growth Rates CYBN's Ps Price to Sales ratio CYBN's Sales per Employee CYBN's Asset Turnover Ratio
CYBN's Net Margin CYBN's Pb Price to Book ratio CYBN's Financial Strength Ratios CYBN's Dividend Payout Ratio
Date modified: 2026-07-07T10:16:31+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2025Number of Employees Mar 31 2025
Agilon Health Inc   6,996,446.26 $ 5,988.958  Million 856 
Cybin Inc   5,304,933.00 $ 159.148  Million 30 
Anika Therapeutics Inc   4,961,714.29 $ 104.196  Million 21 
P3 Health Partners Inc   4,641,225.00 $ 1,485.192  Million 320 
Aytu Biopharma Inc  4,280,187.50 $ 68.483  Million 16 
Community Health Systems Inc   4,081,612.90 $ 12,653.000  Million 3,100 
Ligand Pharmaceuticals Incorporated  3,857,276.60 $ 181.292  Million 47 
Xeris Biopharma Holdings Inc   3,423,861.54 $ 222.551  Million 65 
Illumina Inc   3,388,281.25 $ 4,337.000  Million 1,280 
Ironwood Pharmaceuticals inc   3,176,760.00 $ 317.676  Million 100 
Keros Therapeutics Inc   3,066,602.56 $ 239.195  Million 78 
Xoma Royalty Corporation  3,064,928.57 $ 42.909  Million 14 
Catalyst Pharmaceuticals Inc   2,937,615.38 $ 534.646  Million 182 
Verve Therapeutics Inc   2,838,714.29 $ 59.613  Million 21 
Sarepta Therapeutics Inc   2,674,695.81 $ 2,233.371  Million 835 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.